In a lawsuit filed this week, separation science firm Phenomenex accused Thermo Fisher Scientific of false advertising in an e-mail that compared each company's liquid chromatography columns.

The suit was filed in US District Court, Central District of California.

In its complaint, Phenomenex, based in Torrance, Calif. alleges that a Thermo Fisher manager for LC and LC-MS columns sent an e-mail on or about Oct. 17 to that firm's distributors. The e-mail contained false and misleading claims about Phenomenex's Kinetex LC columns, Phenomenex alleges.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.